Results 91 to 100 of about 1,366 (168)

Targeting senescence‐associated secretory phenotypes to remodel the tumour microenvironment and modulate tumour outcomes

open access: yesClinical and Translational Medicine
Tumour cell senescence can be induced by various factors, including DNA damage, inflammatory signals, genetic toxins, ionising radiation and nutrient metabolism.
Jiaqiang Xiong   +8 more
doaj   +1 more source

Therapy-induced senescence through the redox lens

open access: yesRedox Biology
Therapy-induced senescent tumor cells have emerged as significant drivers of tumor recurrence and disease relapse. Interestingly, reactive oxygen species (ROS) production and its associated redox signaling networks are intertwined with initiation and ...
Matius Robert   +2 more
doaj   +1 more source

Editorial: Cellular Senescence: Causes, Consequences and Therapeutic Opportunities

open access: yesFrontiers in Cell and Developmental Biology, 2022
Pooi-Fong Wong
doaj   +1 more source

Epigenetic dysregulation in cardiovascular aging and disease

open access: yes, 2021
Cardiovascular disease (CVD) is the leading cause of mortality and morbidity for all sexes, racial and ethnic groups. Age, and its associated physiological and pathological consequences, exacerbate CVD incidence and progression, while modulation of ...
Occean, James R.   +2 more
core  

Connecting epigenetics and inflammation in vascular senescence: state of the art, biomarkers and senotherapeutics

open access: yesFrontiers in Genetics
Vascular diseases pose major health challenges, and understanding their underlying molecular mechanisms is essential to advance therapeutic interventions. Cellular senescence, a hallmark of aging, is a cellular state characterized by cell-cycle arrest, a
Oscar Fraile-Martinez   +31 more
doaj   +1 more source

SENOTHERAPEUTICS, AGING, AND AGE-RELATED DISEASES [PDF]

open access: yesInnov Aging
Abstract Increased translational clinical trials are addressing the utility of senotherapeutic agents as interventions for aging in general and for age-related diseases. Numerous pre-clinical trials have provided a good rationale for human clinical trials which are being increasingly proposed.
europepmc   +2 more sources

Senotherapeutic potential against xeroderma pigmentosum

open access: yes
Abstract Xeroderma pigmentosum (XP) is an inherited photoaging syndrome caused by mutations in genes involved in the nucleotide excision repair (NER) pathway. XP patients exhibit hypersensitivity to ultraviolet (UV) radiation, leading to accelerated skin aging and requiring lifelong sun avoidance.
Xuebing Wang   +8 more
openaire   +1 more source

Insights on geroscience pre-clinical and clinical trials to promote healthy aging from the Intrinsic Capacity, Frailty and Sarcopenia Research Task Force 2025. [PDF]

open access: yesJ Frailty Aging
Tagliafico L   +7 more
europepmc   +1 more source

Real-World Clinical Practice on Skin Rejuvenation Among Korean Board-Certified Dermatologists: Survey-Based Results. [PDF]

open access: yesAnn Dermatol
Oh S   +14 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy